Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 16 Mar 2023
Avascular necrosis (AVN) is considered an iatrogenic complication after treatment for progressive hip dysplasia, but research in China has revealed two characteristics associated with this condition. ossification nuclei.
Read Full NewsLack of access to innovative and effective treatments compromises survival outcomes for many patients in Europe with multiple myeloma.
A large study links the use of e-cigarettes after smoking cessation to higher lung cancer incidence and mortality than complete nicotine abstinence.
Post hoc analysis of the MajesTEC-3 trial shows the efficacy of the teclistamab plus daratumumab combination in hard-to-treat patients with high cytogenetic and functional risk.
Guidelines on treating cancer fatigue offer little enthusiasm for methylphenidate and other stimulants. But a recent meta-analysis suggests the medications deserve a rethink.
1.
Enthusiasm for Transplant-Free Strategies for Low-Risk Relapsed Hodgkin Lymphoma
2.
Life quality after childhood cancer is quantifiable thanks to outcome indicators.
3.
Muscular strength and good physical fitness linked to lower risk of death in people with cancer
4.
Study reveals link between new-onset type 2 diabetes and some obesity-related cancers
5.
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire
1.
Essential Techniques in Hematology for Better Care
2.
HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways
3.
Mastering Prostate Cancer Care: CME, Certification, Digital Tools, and Evidence-Based Strategies
4.
Innovative Bioengineering Approaches for Erectile Function Recovery After Radical Prostatectomy
5.
The latest research on Iron Binding Capacity: The Little-Known Factor That Could Impact Your Health v
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II
2.
An In-Depth Look At The Signs And Symptoms Of Lymphoma- The Q & A Session
3.
Managing ALK+ NSCLC while Ensuring Long-Term Safety of the Patients
4.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management
5.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge